283
Views
54
CrossRef citations to date
0
Altmetric
Original Research

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?

, , , , &
Pages 29-36 | Published online: 10 Jan 2013

References

  • SloanFAValuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical TechnologiesNew YorkCambridge University Press1995
  • WHO Commission on Macroeconomics and HealthInvesting in health for economic development Report of the Commission on Macroeconomics and HealthGenevaWorld Health Organization2001
  • GrosseSDAssessing cost-effectiveness in healthcare: history of the $50,000 per QALY thresholdExpert Rev Pharmacoecon Outcomes Res20088216517820528406
  • HirthRAChernewMEMillerEWillingness to pay for a quality-adjusted life year: in search of a standardMed Decis Making200020333234210929856
  • UbelPHirthRAChernewMEWhat is the price of life and why doesn’t it increase at the rate of inflation?Arch Intern Med2003163141637164112885677
  • MasonHBakerRDonaldsonCWillingness to pay for a QALY: past, present, and futureExpert Rev Pharmacoecon Outcomes Res20088657558220528368
  • BrouwerWvan ExelJBakerRThe new myth: the social value of the QALYPharmaco Economics200826114
  • Gyrd-HansenDWillingness to pay for a QALY: theoretical and methodological issuesPharmaco Economics2005235423432
  • JohnsonFREinstein on willingness to pay per QALY: is there a better way?Med Decis Making200525660760816282210
  • LieuTARayGTOrtega-SanchezIRWillingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zosterPharmaco Economics2009271210051016
  • DonaldsonCBakerRMasonHThe social value of a QALY: raising the bar or barring the raise?BMC Health Serv Res2011;11(8) Available from: http://www.biomedcentral.com/1472-6963/11/8Accessed July 10, 2012
  • BobinacAvan ExelNJRuttenFFWillingness to pay for a quality-adjusted life year: the individual perspectiveValue in Health20101381046105520825620
  • NordEDanielsNKamletMQALYs: some challengesValue in Health200912s1S10S1519250125
  • ZhaoFLYueMYangHWillingness to pay per quality-adjusted life year: is one threshold enough for decision-making? Results from a study in patients with chronic prostatitisMed Care201149326727221224742
  • O BrienBJGertsenKWillanARIs there a kink in consumer’s threshold value for cost-effectiveness in health care?Health Econ2002111217518011921315
  • LeeGMSalomonJAGayCPreferences for health outcomes associated with group A streptococcal disease and vaccinationHealth and Quality of Life Outcomes2010;8(1)Available fromhttp://www.hqlo.com/content/8/1/28Accessed August 10, 2011
  • ByrneMMO’MalleyKSuarez-AlmazorMEWillingness to pay per quality-adjusted life year in a study of knee osteoarthritisMed Decis Making200525665566616282216
  • CunninghamSJHuntN PRelationship between utility values and willingness to pay in patients undergoing orthognathic treatmentCommunity Dent Health2000172929611349993
  • KingJTTsevatJLaveJRWillingness to pay for a quality-adjusted life year: implications for societal health care resource allocationMed Decis Making200525666767716282217
  • ZethraeusNWillingness to pay for hormone replacement therapyHealth Econ19987131389541082
  • Gyrd-HansenDWillingness to pay for a QALYHealth Econ20031211049106014673813
  • DonaldsonCBakerRMasonHEuropean Value of a Quality Adjusted Life Year. Final publishable report2010http://research.ncl.ac.uk/eurovaq/EuroVaQ_Final_Publishable_Report_and_Appendices.pdfAccessed March 20, 2011
  • ShiroiwaTSungYKFukudaTInternational survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?Health Econ201019442243719382128
  • JirawattanapisalTKingkaewPLeeTJEvidence-based decision-making in Asia-Pacific with rapidly changing health-care systems: Thailand, South Korea, and TaiwanValue in Health200912s3S4S1120586980
  • VaughanWJRussellCSDarlingAHDetermining the optimal sample size for contingent valuation surveysTennesseeDepartment of Economics, Vanderbilt University2000
  • International Monetary FundWorld Economic Outlook Database (WEO)2010http://www.imf.org/external/pubs/ft/weo/2010/01/weodata/index.aspxAccessed January 5, 2012
  • PermsuwanUGuntawongwanKBuddhawongsaPHandling time in economic evaluation studiesJournal of the Medical Association of Thailand200891s2S43S5319253487
  • JohannessonMJonssonBKarlsonGOutcome measured in economic evaluationHealth Econ1996542792968880165
  • NordECost–value Analysis in Health Care Making Sense Out of QALYsNew YorkCambridge University Press1999
  • BosJMPostmaMJUsing pharmacoeconomics for policy making: is rational decision making enhanced by applying thresholds for cost-effectivenessExpert Rev Pharmacoecon Outcome Res200443247250
  • FreemantleNValuing the effects of sildenafil in erectile dysfunctions. Strong assumptions are required to generate a QALY valueBr Med J200032072431156115710784525
  • RheingansRDHaddixACMessonnierMLWillingness to pay for prevention and treatment of lymphatic filariasis in LeoganeHaiti. Filaria J2004312
  • KahnemanDTverskyAProspect theory: an analysis of decision under riskEconomietrica19794263291
  • RasielEBWeinfurtK PSchulmanKACan prospect theory explain risk-seeking behavior by terminally ill patients?Med Decis Making200525660961316282211
  • SmithRDRichardsonJCan we estimate the “social” value of a QALY? Four core issues to resolveHealth Policy2005741778416098414
  • WeinsteinMCTorranceGMcGuireAQALYs: the basicsValue in Health200912s1S5S919250132